Cargando…
Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials
Protein–protein interactions (PPIs) have pivotal roles in life processes. The studies showed that aberrant PPIs are associated with various diseases, including cancer, infectious diseases, and neurodegenerative diseases. Therefore, targeting PPIs is a direction in treating diseases and an essential...
Autores principales: | Lu, Haiying, Zhou, Qiaodan, He, Jun, Jiang, Zhongliang, Peng, Cheng, Tong, Rongsheng, Shi, Jianyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511340/ https://www.ncbi.nlm.nih.gov/pubmed/32968059 http://dx.doi.org/10.1038/s41392-020-00315-3 |
Ejemplares similares
-
Ganoderma lucidum: Current advancements of characteristic components and experimental progress in anti-liver fibrosis
por: Peng, Haoyuan, et al.
Publicado: (2023) -
Recent Advances in Protein–Protein Interactions
por: Sedov, Igor A., et al.
Publicado: (2023) -
Cationic micelle-based siRNA delivery for efficient colon cancer gene therapy
por: Lu, Yongping, et al.
Publicado: (2019) -
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
por: Xie, Xin, et al.
Publicado: (2023) -
Emetine, a small molecule natural product, displays potent anti-gastric cancer activity via regulation of multiple signaling pathways
por: Peng, Xuerun, et al.
Publicado: (2023)